These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21411753)

  • 1. Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis.
    Natarajan R
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):725-7. PubMed ID: 21411753
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
    Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.
    Qing H; Aono J; Findeisen HM; Jones KL; Heywood EB; Bruemmer D
    J Cell Physiol; 2016 Jun; 231(6):1276-82. PubMed ID: 26505494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
    Mathew OP; Ranganna K; Yatsu FM
    Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking potassium channels: a new principle for treating restenosis?
    Olschewski A
    Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential epigenetic therapeutics for atherosclerosis treatment.
    Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
    Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.
    Yang Q; Lu Z; Ramchandran R; Longo LD; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L1001-10. PubMed ID: 23043075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
    Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
    Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panobinostat reverses HepaCAM gene expression and suppresses proliferation by increasing histone acetylation in prostate cancer.
    Chen E; Liu N; Zhao Y; Tang M; Ou L; Wu X; Luo C
    Gene; 2022 Jan; 808():145977. PubMed ID: 34592353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in vascular disease - therapeutic potential of new agents.
    Xu SS; Alam S; Margariti A
    Curr Vasc Pharmacol; 2014 Jan; 12(1):77-86. PubMed ID: 22724461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.
    Sauter A; Landers A; Dittmann H; Pritzkow M; Wiesinger B; Bayer M; Bantleon R; Schmehl J; Claussen CD; Kehlbach R
    J Vasc Interv Radiol; 2011 May; 22(5):623-9. PubMed ID: 21414804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
    Sharma V; Koul N; Joseph C; Dixit D; Ghosh S; Sen E
    J Cell Mol Med; 2010 Aug; 14(8):2151-61. PubMed ID: 19583803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain.
    Yan ZQ; Yao QP; Zhang ML; Qi YX; Guo ZY; Shen BR; Jiang ZL
    J Biomech; 2009 May; 42(7):945-8. PubMed ID: 19261284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury.
    Zhou B; Zeng S; Li N; Yu L; Yang G; Yang Y; Zhang X; Fang M; Xia J; Xu Y
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):675-684. PubMed ID: 28153879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1.
    Lee DY; Won KJ; Lee KP; Jung SH; Baek S; Chung HW; Choi WS; Lee HM; Lee BH; Jeon BH; Kim B
    Toxicol Appl Pharmacol; 2018 May; 347():45-53. PubMed ID: 29609002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K9 acetylation and radial chromatin positioning.
    Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
    J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.